Harris, Jennifer Leslie,Li, Nanxin,Smith, Timothy R.
申请号：
AU2014312261
公开号：
AU2014312261A1
申请日:
2014.08.28
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to a pharmaceutical combination comprising, separately or together, (1) a first agent which is an ALK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof. The invention further relates the use of such combination in the treatment or prevention of proliferative diseases.
